The Effect of Omega-3 Fatty Acid Supplementation on Behavior of Children With ADHD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Attention Deficit Hyperactivity Disorder
- Sponsor
- Hadassah Medical Organization
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- ADHD symptoms
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
It is assumed that only 1/5 of children diagnosed with attention-deficit-hyperactivity disorder (ADHD) are treated. New treatment modalities are urgently needed. Omega-3 fatty acids have been used in this setting, yet results are conflicting. The parent omega-3 fatty acid alpha-linolenic acid (ALA) has only been used in one trial. 40 children diagnosed with ADHD will be randomized to consume either ALA or placebo for two months. Baseline and end assessments will include ADHD-related questionnaires and a computerized test. The investigators hypothesize that ALA supplementation will prove beneficial for children with ADHD.
Investigators
gal dubnov raz
Senior physician
Sheba Medical Center
Eligibility Criteria
Inclusion Criteria
- •ADHD diagnosis
- •informed consent
Exclusion Criteria
- •refusal of any testing
- •any comorbidities
- •any medication or supplement use
Outcomes
Primary Outcomes
ADHD symptoms
Time Frame: 8 weeks
scores of DSM and Conners questionnaires
Secondary Outcomes
- Computerized test performance(8 weeks)